Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 1 opinions in the last 12 months.
Chemed Corporation, trading under the symbol CHE-N, is experiencing significant growth, particularly in its hospice business, which is expanding at double-digit rates. This positive trajectory suggests a robust demand for their services amid an evolving healthcare landscape. Experts highlight the company's solid operational strategies and management effectiveness, indicating a strong position within the industry. As the aging population continues to rise, Chemed's focus on hospice care positions it well for sustained future growth. Overall, the sentiment towards the company remains optimistic, with expectations of continued performance improvements in the coming quarters.
Chemed Corporation is a American stock, trading under the symbol CHE-N on the New York Stock Exchange (CHE). It is usually referred to as NYSE:CHE or CHE-N
In the last year, 1 stock analyst published opinions about CHE-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Chemed Corporation.
Chemed Corporation was recommended as a Top Pick by on . Read the latest stock experts ratings for Chemed Corporation.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Chemed Corporation In the last year. It is a trending stock that is worth watching.
On 2025-05-05, Chemed Corporation (CHE-N) stock closed at a price of $576.07.
She added more. The hospice business is growing double-digits.